
    
      Up to 400 females will participate in this study in one of three cohorts:

        -  150 females ages 11-35, with history of exposure to alkylating agent chemotherapy and/or
           radiation therapy

        -  150 Unexposed peers, ages 11-35, never exposed to chemotherapy or radiation therapy

        -  100 Unexposed females, ages 40-50 never exposed to chemotherapy or radiation therapy
    
  